Investing in our Product Development
We currently offer six investment opportunities in multiple therapeautic arenas.
- TriThroid®t: The newest Thyroid Hormone supplement to treat Hypothyroidism. TriThroid® is our T3 drug, in addition our BCT304 T4 drug soon to enter clinical Trials, as well as our BCT 305 and 306 combo T4 and T3 drugs.
- Blu-T(tm): A patented Cancer Diagnostic.
- Nerodegenerative disease drugs including Parkinoltmand Azolol(tm)
- ADHD drug treatment products including Polyphetamine
- Wound healing and tissue repair: including Loopin.
- Myocardial Infarct therapy: including CardioSafe(tm)